Already a Bloomberg.com user?
Sign in with the same account.
Bloomberg's Tom Gibson reports on the French company making money from snakes and scorpions by selling their venom to the pharmaceutical industry.
On Air Now
Taking Stock with Pimm Fox Watch Now
Next
The Real Brazil